Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Legend Biotech Corporation · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $2.83B | $2.53B - $3.12B | -$1.93B | $2.125 | 5 |
| Dec 2029 | $2.51B | $2.24B - $2.76B | -$1.71B | $1.612 | 5 |
| Dec 2028 | $2.12B | $2.10B - $2.14B | -$1.44B | $1.671 | 10 |
| Dec 2027 | $1.81B | $1.55B - $2.00B | -$1.23B | $0.921 | 11 |
| Dec 2026 | $1.43B | $1.36B - $1.54B | -$977.38M | $0.091 | 11 |
| Dec 2025 | $1.03B | $1.01B - $1.05B | -$701.73M | -$0.791 | 10 |
| Dec 2024 | $620.51M | $602.35M - $646.43M | -$422.71M | -$0.84 | 15 |
| Dec 2023 | $455.99M | $406.82M - $502.79M | -$310.64M | -$1.566 | 11 |
| Dec 2022 | $131.97M | $119.02M - $153.86M | -$110.34M | -$1.40 | 4 |
| Dec 2021 | $72.44M | $65.33M - $84.45M | -$60.57M | -$1.559 | 5 |
| Dec 2020 | $51.63M | $46.57M - $60.20M | -$43.17M | -$1.37 | 5 |